Amphenol (APH) EPS Estimated At $0.72; Kite Pharma (KITE) Covered By 13 Bulls

July 17, 2017 - By Maria Brooks

Among 19 analysts covering Kite Pharma (NASDAQ:KITE), 13 have Buy rating, 1 Sell and 5 Hold. Therefore 68% are positive. Kite Pharma had 43 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, November 13 by Stifel Nicolaus. The stock of Kite Pharma Inc (NASDAQ:KITE) earned “Buy” rating by FBR Capital on Friday, May 26. The company was maintained on Friday, August 14 by Guggenheim. The company was maintained on Monday, June 26 by Jefferies. The firm has “Buy” rating by BTIG Research given on Thursday, June 8. The firm has “Buy” rating by TH Capital given on Wednesday, January 4. FBR Capital maintained Kite Pharma Inc (NASDAQ:KITE) on Friday, November 13 with “Mkt Perform” rating. The stock of Kite Pharma Inc (NASDAQ:KITE) has “Outperform” rating given on Thursday, June 2 by Raymond James. The rating was initiated by Citigroup on Thursday, February 25 with “Buy”. The rating was maintained by Maxim Group with “Buy” on Wednesday, March 1. See Kite Pharma Inc (NASDAQ:KITE) latest ratings:

13/07/2017 Broker: Maxim Group Old Rating: Buy New Rating: Hold Downgrade
10/07/2017 Broker: Canaccord Genuity Rating: Buy New Target: $115.0000 Maintain
27/06/2017 Broker: Canaccord Genuity Rating: Buy New Target: $115.0000 Maintain
26/06/2017 Broker: Cowen & Co Rating: Buy Maintain
26/06/2017 Broker: Jefferies Rating: Buy New Target: $101.0000 Maintain
08/06/2017 Broker: Jefferies Rating: Buy Maintain
07/06/2017 Broker: Cowen & Co Rating: Buy Maintain
06/06/2017 Broker: Canaccord Genuity Rating: Buy New Target: $90.0000 Maintain
08/06/2017 Broker: BTIG Research Old Rating: Neutral New Rating: Buy Upgrade
30/05/2017 Broker: Standpoint Research Rating: Hold

Analysts expect Amphenol Corporation (NYSE:APH) to report $0.72 EPS on July, 26 before the open.They anticipate $0.07 EPS change or 10.77% from last quarter’s $0.65 EPS. APH’s profit would be $219.91M giving it 25.89 P/E if the $0.72 EPS is correct. After having $0.71 EPS previously, Amphenol Corporation’s analysts see 1.41% EPS growth. The stock decreased 0.05% or $0.04 on July 14, reaching $74.55. About shares traded. Amphenol Corporation (NYSE:APH) has risen 31.78% since July 17, 2016 and is uptrending. It has outperformed by 15.08% the S&P500.

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $5.81 billion. The Firm is focused on the development and commercialization of cancer immunotherapy products to target and kill cancer cells. It currently has negative earnings. The Firm offers engineered autologous cell therapy, which is an approach to the treatment of cancer.

Since January 31, 2017, it had 5 insider buys, and 19 insider sales for $21.22 million activity. On Monday, March 27 BUTITTA CYNTHIA M sold $776,746 worth of Kite Pharma Inc (NASDAQ:KITE) or 10,000 shares. On Wednesday, June 7 DOUMANI ROY sold $1.27M worth of Kite Pharma Inc (NASDAQ:KITE) or 15,000 shares. Kim Helen Susan sold $173,880 worth of stock. 20,000 shares were sold by Chang David D, worth $1.63M on Monday, April 3. Nussbaum Ran bought 9,832 shares worth $679,474. $76,820 worth of Kite Pharma Inc (NASDAQ:KITE) was sold by Wiezorek Jeffrey. $1.84M worth of Kite Pharma Inc (NASDAQ:KITE) shares were sold by CHAMPSI FARAH.

Investors sentiment decreased to 1.31 in 2016 Q4. Its down 0.32, from 1.63 in 2016Q3. It dropped, as 34 investors sold Kite Pharma Inc shares while 43 reduced holdings. 30 funds opened positions while 71 raised stakes. 43.05 million shares or 17.06% more from 36.77 million shares in 2016Q3 were reported. Gru One Trading Lp stated it has 14,608 shares. Wildcat Cap Mngmt Limited Co accumulated 2.36M shares. Howard Hughes Medical Institute holds 893 shares or 0.01% of its portfolio. Hudock Capital Group Ltd Liability Company holds 0.01% or 350 shares in its portfolio. Raymond James Fincl Svcs Advisors Inc has 21,466 shares. Proshare Ltd Liability Corp stated it has 39,880 shares. California State Teachers Retirement Systems holds 0.01% in Kite Pharma Inc (NASDAQ:KITE) or 80,769 shares. Rhenman Ptnrs Asset Mngmt Ab holds 0.69% or 80,000 shares. Wells Fargo & Mn holds 0% of its portfolio in Kite Pharma Inc (NASDAQ:KITE) for 66,481 shares. Amer Century Companies reported 0.03% of its portfolio in Kite Pharma Inc (NASDAQ:KITE). 32,413 were accumulated by Sg Americas Securities Limited Liability Co. Jpmorgan Chase And Company has 2.99 million shares. Us Bancorp De owns 6 shares. Highline Cap Mngmt Limited Partnership, a New York-based fund reported 702,300 shares. 10,000 are owned by Federated Invsts Pa.

The stock decreased 0.26% or $0.27 on July 14, reaching $103.09. About shares traded. Kite Pharma Inc (NASDAQ:KITE) has risen 55.47% since July 17, 2016 and is uptrending. It has outperformed by 38.77% the S&P500.

Investors sentiment decreased to 0.9 in 2016 Q4. Its down 0.10, from 1 in 2016Q3. It worsened, as 34 investors sold Amphenol Corporation shares while 200 reduced holdings. 56 funds opened positions while 154 raised stakes. 296.91 million shares or 1.03% more from 293.87 million shares in 2016Q3 were reported. Monetary Mgmt Gru holds 1,200 shares. Tarbox Grp Incorporated has invested 0% in Amphenol Corporation (NYSE:APH). Eagle Asset Management reported 0.2% in Amphenol Corporation (NYSE:APH). Hancock Holding Communication owns 5,272 shares or 0.01% of their US portfolio. Barclays Public Limited Company has 0.04% invested in Amphenol Corporation (NYSE:APH) for 619,483 shares. Livforsakringsbolaget Skandia Omsesidigt reported 0.06% of its portfolio in Amphenol Corporation (NYSE:APH). Quantitative Investment Mngmt Llc reported 56,000 shares. Jensen Investment Management has invested 2.36% in Amphenol Corporation (NYSE:APH). Howland Mngmt Limited Liability Corporation owns 166,273 shares for 1.04% of their portfolio. Blair William And Co Il has 972,720 shares. First Natl Bank Of Mount Dora Ser holds 1.95% or 49,040 shares. 249,974 were accumulated by Apg Asset Mngmt Nv. Old Mutual Customised Solutions (Proprietary) Limited accumulated 2,300 shares or 0.03% of the stock. Federated Inc Pa invested in 0% or 7,597 shares. Nomura Holdings stated it has 28,195 shares or 0% of all its holdings.

Among 7 analysts covering Amphenol (NYSE:APH), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Amphenol had 24 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Suntrust Robinson given on Thursday, January 21. The rating was maintained by Stifel Nicolaus on Thursday, April 27 with “Hold”. The firm has “Buy” rating given on Wednesday, August 26 by Zacks. RBC Capital Markets maintained the shares of APH in report on Thursday, June 1 with “Buy” rating. As per Monday, January 18, the company rating was maintained by RBC Capital Markets. The firm has “Top Pick” rating by RBC Capital Markets given on Wednesday, November 30. On Monday, November 16 the stock rating was upgraded by Goldman Sachs to “Buy”. The stock of Amphenol Corporation (NYSE:APH) has “Hold” rating given on Tuesday, December 15 by Drexel Hamilton. The company was maintained on Thursday, July 23 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Thursday, April 27 with “Top Pick”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: